Introducing Countercurrents—a new feature of Current Oncology

Por Foulkes, W.D.
Publicado em 2011

Size surprise? Tumour size, nodal status, and outcome after breast cancer

Por Foulkes, W.D.
Publicado em 2012

Preventing ovarian cancer by salpingectomy

Por Foulkes, W.D.
Publicado em 2013

Preventing ovarian cancer by salpingectomy

Por Foulkes, W.D.
Publicado em 2013

Screening mammography: the turning of the tide?

Por Foulkes, W.D.
Publicado em 2014

Pancreatic adenocarcinoma: epidemiology and genetics.

Por Flanders, T Y, Foulkes, W D
Publicado em 1996

Clinical implications of next-generation sequencing for cancer medicine

Por Shuen, A., Foulkes, W.D.
Publicado em 2010

Triple-negative and basal-like breast cancer: implications for oncologists

Por Lachapelle, J., Foulkes, W.D.
Publicado em 2011

Pheochromocytoma and paraganglioma syndromes: genetics and management update

Por Lefebvre, M., Foulkes, W.D.
Publicado em 2014

Many mosaic mutations

Por Foulkes, W.D., Real, F.X.
Publicado em 2013

Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.

Por Englefield, P., Foulkes, W. D., Campbell, I. G.
Publicado em 1994

Rhabdomyolysis after intramuscular iron-dextran in malabsorption.

Por Foulkes, W D, Sewry, C, Calam, J, Hodgson, H J
Publicado em 1991

No association betweenP53codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck

Por Hamel, N, Black, M J, Ghadirian, P, Foulkes, W D
Publicado em 2000

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Por Foulkes, W. D., Campbell, I. G., Stamp, G. W., Trowsdale, J.
Publicado em 1993

The CDKN2A (p16) gene and human cancer.

Por Foulkes, W. D., Flanders, T. Y., Pollock, P. M., Hayward, N. K.
Publicado em 1997

Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness

Por Tischkowitz, M, Gologan, A, Srolovitz, H, Khanna, M, Foulkes, W D
Publicado em 2006

Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family

Por McVety, S, Li, L, Gordon, P H, Chong, G, Foulkes, W D
Publicado em 2006

Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis

Por Bernatsky, S, Ramsey-Goldman, R, Foulkes, W D, Gordon, C, Clarke, A E
Publicado em 2011

Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression.

Por Naylor, M S, Stamp, G W, Foulkes, W D, Eccles, D, Balkwill, F R
Publicado em 1993

Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma.

Por Foulkes, W. D., Ragoussis, J., Stamp, G. W., Allan, G. J., Trowsdale, J.
Publicado em 1993